Answer
Pharmaceutical incompatibilities are listed as “Not applicable” for the Glenmark Pharmaceuticals Europe Ltd product’s efavirenz/emtricitabine/tenofovir disoproxil film-coated tablets.
Sources for this answer
- Efavirenz/Emtricitabine/Tenofovir disoproxil Glenmark 600 mg/ 200 mg/245 mg film-coated tabletsGlenmark Pharmaceuticals Europe Ltd · emc · SmPC §6.2 Incompatibilities · Version 5Document updated
Sources checked